Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Smith

Showing results (231-240 of 288) with videos related to

Pageof 29
Sort By:
American Journal of Preventive Medicine|February 25, 2026
Impact of Serotype Uncertainty on Adult Pneumococcal Vaccine Options: A Value of Information AnalysisAngela R Wateska, Shoroq M Altawalbeh, Mary Patricia Nowalk, et al.
Physiological Measurement|December 22, 2016
A multispectral microscope for in vivo oximetry of rat dorsal spinal cord vasculatureMarieke A van der Putten, Lewis E MacKenzie, Andrew L Davies, et al.
Vaccine|July 3, 2025
Cost-effectiveness and budget impact analyses of the 24-valent pneumococcal conjugate vaccine in adults aged 50 and olderShoroq M Altawalbeh, Angela R Wateska, Mary Patricia Nowalk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 10, 2024
Pneumococcal Vaccination Strategies in 50-Year-Olds to Decrease Racial Disparities: A US Societal Perspective Cost-Effectiveness AnalysisShoroq M Altawalbeh, Angela R Wateska, Mary Patricia Nowalk, et al.
American Journal of Clinical Oncology|March 26, 2025
Cost-Effectiveness Analysis of Tumor Testing for BRCA Pathogenic Variants in Epithelial Ovarian CancerSarah E Taylor, Phuong L Mai, Heidi Donovan, et al.
Public Health|October 29, 2025
Public health effects of adult pneumococcal vaccination choice amid increased serotype 4 rates in US subpopulationsKenneth J Smith, Angela R Wateska, Mary Patricia Nowalk, et al.
Journal of the American Geriatrics Society|June 1, 2024
Changes in the cost-effectiveness of pneumococcal vaccination and of programs to increase its uptake in U.S. older adultsAngela R Wateska, Mary Patricia Nowalk, Shoroq M Altawalbeh, et al.
The American Journal of Managed Care|July 22, 2010
Screening cardiac surgery patients for MRSA: an economic computer modelBruce Y Lee, Ann E Wiringa, Rachel R Bailey, et al.
Cardiovascular Research|May 5, 2018
Understanding the role of the perivascular space in cerebral small vessel diseaseRosalind Brown, Helene Benveniste, Sandra E Black, et al.
Physical Therapy|November 1, 2017
Exercise, Manual Therapy, and Booster Sessions in Knee Osteoarthritis: Cost-Effectiveness Analysis From a Multicenter Randomized Controlled TrialAllyn M Bove, Kenneth J Smith, Christopher G Bise, et al.
Pageof 29

Showing results (231-240 of 288) with videos related to

Sort By:
Pageof 29
American Journal of Preventive Medicine|February 25, 2026
Impact of Serotype Uncertainty on Adult Pneumococcal Vaccine Options: A Value of Information AnalysisAngela R Wateska, Shoroq M Altawalbeh, Mary Patricia Nowalk, et al.
Physiological Measurement|December 22, 2016
A multispectral microscope for in vivo oximetry of rat dorsal spinal cord vasculatureMarieke A van der Putten, Lewis E MacKenzie, Andrew L Davies, et al.
Vaccine|July 3, 2025
Cost-effectiveness and budget impact analyses of the 24-valent pneumococcal conjugate vaccine in adults aged 50 and olderShoroq M Altawalbeh, Angela R Wateska, Mary Patricia Nowalk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 10, 2024
Pneumococcal Vaccination Strategies in 50-Year-Olds to Decrease Racial Disparities: A US Societal Perspective Cost-Effectiveness AnalysisShoroq M Altawalbeh, Angela R Wateska, Mary Patricia Nowalk, et al.
American Journal of Clinical Oncology|March 26, 2025
Cost-Effectiveness Analysis of Tumor Testing for BRCA Pathogenic Variants in Epithelial Ovarian CancerSarah E Taylor, Phuong L Mai, Heidi Donovan, et al.
Public Health|October 29, 2025
Public health effects of adult pneumococcal vaccination choice amid increased serotype 4 rates in US subpopulationsKenneth J Smith, Angela R Wateska, Mary Patricia Nowalk, et al.
Journal of the American Geriatrics Society|June 1, 2024
Changes in the cost-effectiveness of pneumococcal vaccination and of programs to increase its uptake in U.S. older adultsAngela R Wateska, Mary Patricia Nowalk, Shoroq M Altawalbeh, et al.
The American Journal of Managed Care|July 22, 2010
Screening cardiac surgery patients for MRSA: an economic computer modelBruce Y Lee, Ann E Wiringa, Rachel R Bailey, et al.
Cardiovascular Research|May 5, 2018
Understanding the role of the perivascular space in cerebral small vessel diseaseRosalind Brown, Helene Benveniste, Sandra E Black, et al.
Physical Therapy|November 1, 2017
Exercise, Manual Therapy, and Booster Sessions in Knee Osteoarthritis: Cost-Effectiveness Analysis From a Multicenter Randomized Controlled TrialAllyn M Bove, Kenneth J Smith, Christopher G Bise, et al.
Pageof 29